FRANKFURT, GERMANY: AI/ML Innovations Inc., a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is now listed for trading on the Frankfurt Stock Exchange.

AI/ML Innovations Inc. is now listed on the Frankfurt Stock Exchange (also known as the Deutsche Boerse AG), one of the largest stock exchanges in the world, under WKN: A2QMBE and the symbol: 42FB. The company’s shares continue to be listed on the Canadian Securities Exchange under the symbol: AIML, as well as continuing to trade on the OTCQB under the symbol: AIMLF

The Frankfurt listing will increase the visibility of the Company amongst European investors and will make it easier for both institutional and retail investors across Europe to participate in the market for AIML shares.

“We are very pleased to improve the access to our shares for our growing followers across the European Union”, said Tim Daniels, Chairman of AI/ML Innovations Inc.

“As we expand our corporate footprint into Europe by way of our investment in France-based Tech2Heal, we are seeing a corresponding increase in interest from European based investors who will benefit from our Frankfurt listing.”

Additionally, the Company announces that it has entered an agreement with the Swiss based advisor, Pro Return AG to provide AIML with capital markets consulting services internationally.

Pro Return shall focus on international markets with the goal of introductions to institutional investors in order to finance the Company, with consulting services to include a review of the Company’s business plans, corporate presentations and general corporate development materials.

The contract is set to run for a 17-month period commencing August 1, 2021 through December 31, 2022 at a cost of €23,530 per month. Pro Return AG is arms-length from AIML.

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum.

Through strategic partnerships with Health Gauge, Tech2Health and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company’s stakeholders. AI/ML’s shares are traded on the Canadian Securities Exchange under the symbol “AIML” and on the OTCQB Venture Market under “AIMLF”.